August 7, 2013 — The Southeast Texas Record reports that a woman from Daingerfield, Texas, has filed a Lipitor diabetes lawsuit against Pfizer. The plaintiff started taking Lipitor in 2006 and was diagnosed with type-2 diabetes in 2009. She alleges that Pfizer failed to adequately warn about the risk of diabetes from Lipitor.
The lawsuit was filed on July 23 in the Eastern District of Texas, Marshall Division. The plaintiff and her lawyers are seeking compensation for her medical expenses, physical injury, emotional damage, economic losses, punitive damages, and other losses caused by Lipitor and type-2 diabetes.
Pfizer is now facing a growing litigation involving several Lipitor lawsuits. Plaintiffs are now seeking to centralize these lawsuits into a Multi-District Litigation (MDL), which is similar to a class action. If federal judges create an MDL, future Lipitor lawsuits in Texas would be transferred into one federal court.
Many lawsuits allege that Pfizer has not done enough to warn patients or their doctors about the risk of type-2 diabetes. According to this Drug Safety Communication from the U.S. Food and Drug Administration (FDA) in 2012, studies have linked Lipitor to a 9% increased risk of diabetes. This risk may be 50% higher for post-menopausal women, according to a study published in the Archives of Internal Medicine in February 2012.